 
  ACD/Labs07231008142D

  5  4  0  0  0  0  0  0  0  0  1 V2000
    1.3412    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0138   -1.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550   -1.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0276   -2.2675    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
  3  5  1  0  0  0  0
M  END
>  <HMDB_ID>
HMDB00002

>  <HMDB_Name>
1,3-Diaminopropane

>  <cas_number>
109-76-2

>  <chebi_id>
15725

>  <description>
1,3-Diaminopropane is a stable, flammable and highly hydroscopic fluid.  It is a polyamine that is normally quite toxic if swallowed, inhaled or absorbed through the skin.  It is a catabolic byproduct
 of spermidine.  It is also a precursor in the enzymatic synthesis of beta-alanine.  1, 3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway.

>  <general_references>
3757213|van den Berg GA, Muskiet FA, Kingma AW, van der Slik W, Halie MR: Simultaneous gas-chromatographic determination of free and acetyl-conjugated polyamines in urine. Clin Chem. 1986 Oct;32(10):1
930-7.9226558|Kim KR, Paik MJ, Kim JH, Dong SW, Jeong DH: Rapid gas chromatographic profiling and screening of biologically active amines. J Pharm Biomed Anal. 1997 Jun;15(9-10):1309-18.; 5096953|Brem
er HJ, Kohne E: The excretion of diamines in human urine. II. Cadaverine, putrescine, 1,3-diaminopropane, 2,2'-dithiobis(ethylamine) and spermidine in urine of patients with cystinuria and cystinlysin
uria. Clin Chim Acta. 1971 May;32(3):407-18.1150841|Fleisher JH, Russell DH: Estimation of urinary diamines and polyamines by thin-layer chromatography. J Chromatogr. 1975 Jul 16;110(2):335-40.; 63246
13|Blackburn P, Peterson CM: Thiol-disulfide interchange between cystine and N-2-mercaptoethyl-1, 3-diaminopropane as a potential treatment for cystinuria. Anal Biochem. 1984 Jan;136(1):31-8.; 293750|
Aigner-Held R, Campbell RA, Daves GD Jr: Polyamine-pyridoxal Schiff bases in urine.  Proc Natl Acad Sci U S A. 1979 Dec;76(12):6652-5.; 8624793|Somayaji VV, Guay V, Peng Z, Sykes TR, Noujaim AA: Synth
esis and evaluation of a new bifunctional chelating agent for the preparation of radioimmunoconjugates. Q J Nucl Med. 1995 Dec;39(4):300-10.3308180|van den Berg GA, Schaaf JM, Nagel GT, Teelken AW, Mu
skiet FA: Determination of polyamines and metabolites in cerebrospinal fluid by isotope dilution mass fragmentography, and a clinical application. Clin Chim Acta. 1987 Jun 15;165(2-3):147-54.6713628|M
uskiet FA, van den Berg GA, Kingma AW, Fremouw-Ottevangers DC, Halie MR: Total polyamines and their non-alpha-amino acid metabolites simultaneously determined in urine by capillary gas chromatography,
 with nitrogen-phosphorus detector; and some clinical applications. Clin Chem. 1984 May;30(5):687-95.9464484|Lee SH, Suh JW, Chung BC, Kim SO: Polyamine profiles in the urine of patients with leukemia
.  Cancer Lett. 1998 Jan 9;122(1-2):1-8.

>  <iupac>
Propane-1,3-diamine

>  <kegg_compound_id>
C00986

>  <metlin_id>
5081

>  <omim_id>
Not Available

>  <pubchem_compound_id>
428

>  <secondary_id>
Not Available

>  <smiles_isomeric>
NCCCN

>  <Index>
1,3-propanediamine

>  <SMILES>
NCCCN

>  <InChI>
InChI=1/C3H10N2/c4-2-1-3-5/h1-5H2

$$$$

  ACD/Labs07231008142D

 19 20  0  0  1  0  0  0  0  0  1 V2000
    3.5888   -1.1533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9194   -2.3065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5968   -4.7420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9355   -7.9276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3226   -6.0485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4759   -6.7098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9195   -1.1533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9194   -4.6049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9195   -3.4517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5808   -2.3065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5888   -3.4517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6129   -8.0647    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5403   -7.1211    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5808    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5808   -4.6049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4598   -5.8227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -5.9034    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.2581   -7.7905    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.0727   -3.9436    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  7  1  0  0  0  0
  2 11  1  0  0  0  0
  3  5  1  0  0  0  0
  3  8  1  0  0  0  0
  4  6  1  0  0  0  0
  4 12  1  0  0  0  0
  5 17  1  0  0  0  0
  5  6  1  0  0  0  0
  5 13  1  1  0  0  0
  6 18  1  1  0  0  0
  6 16  1  0  0  0  0
  7 10  2  0  0  0  0
  7 14  1  0  0  0  0
  8 19  1  1  0  0  0
  8 11  1  0  0  0  0
  8 16  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 15  2  0  0  0  0
M  END
>  <HMDB_ID>
HMDB00012

>  <HMDB_Name>
Deoxyuridine

>  <cas_number>
951-78-0

>  <chebi_id>
16450

>  <description>
2'-Deoxyuridine is a naturally occurring nucleoside. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group.  It is considered to be an antimetabolite that is converted to d
eoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies.

>  <general_references>
|Akhrem, A.A. et al., Org. Magn. Reson., 1979, 12, 247, (cmr); 15866500|Li KM, Rivory LP, Clarke SJ: Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric 
pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jun 5;820(1):121-30.       Epub 20
05 Apr 19.9675653|Di Stefano G, Busi C, Derenzini M, Trere D, Fiume L: Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hep
atocarcinomas. Ital J Gastroenterol Hepatol. 1998 Apr;30(2):173-7.|Fox, J.J. et al., Adv. Carbohydr. Chem., 1959, 14, 283, (rev); |Rimerman, R.A. et al., J. Chromatogr., B: Biomed. Appl., 1993, 619, 2
9-35, (5'-triphosphate); |Schinazi, R.F. et al., J. Med. Chem., 1978, 21, 1141, (synth, acid); |Barr, P.J. et al., Tetrahedron, 1980, 36, 1269, (cryst struct); |Ludwig, J. et al., Synthesis, 1982, 32-
34, (5'-phosphate); 3812550|Reidy JA: Deoxyuridine increases folate-sensitive fragile site expression in human lymphocytes. Am J Med Genet. 1987 Jan;26(1):1-5.; |Dematte, N. et al., Comp. Biochem. Phy
siol., B: Comp. Biochem., 1986, 84, 11, (isol, acid); |Rahman, A. et al., Acta Cryst. B, 1972, 28, 2260, (cryst struct); |Sakema, S. et al., Comp. Biochem. Physiol., B: Comp. Biochem., 1985, 82, 107-1
09, (isol); |Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 816A, (ir); |Kikugawa, K. et al., Chem. Pharm. Bull., 1969, 17, 785, (synth, deriv); 6656991|Eells JT, Spector R: Purine and pyrimidin
e base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7.; |Sprecher, C.A. et al., Biopolymers, 1977, 16, 2243, (cd); |Komori, T. et al., Anna
len, 1980, 653-668, (isol); 1906076|Huong PL, Kolk AH, Eggelte TA, Verstijnen CP, Gilis H, Hendriks JT: Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporatio
n. An easy and low cost alternative to radioactive thymidine incorporation. J Immunol Methods. 1991 Jul 5;140(2):243-8.3761048|Kanazawa S, Herbert V: Detection of folate deficiency in alcoholism using
 the peripheral blood lymphocyte deoxyuridine suppression test. J Nutr Sci Vitaminol (Tokyo). 1986 Jun;32(3):251-7.; |Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 374B, (nmr); |Hruska, F.E. 
et al., Can. J. Chem., 1974, 52, 497, (conformn, pmr); |U.S. Pat., 1966, 3 280 104, CA, 66, 38207y; |Lidgren, G. et al., J. Nat. Prod., 1988, 51, 1277-1280, (2'-Deoxy-3-methyluridine); 9930567|Zittoun
 J, Zittoun R: Modern clinical testing strategies in cobalamin and folate deficiency.  Semin Hematol. 1999 Jan;36(1):35-46.; 12638947|Fairbanks LD, Marinaki AM, Carrey EA, Hammans SR, Duley JA: Deoxyu
ridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE). J Inherit Metab Dis. 2002 Nov;25(7):603-4.; 2328792|Remacha A, Barcelo MJ, Pastor M, Ubeda J, Espadaler M, Gimferrer E: The 
deoxyuridine suppression test in peripheral lymphocytes.  Eur J Haematol. 1990 Mar;44(3):196-200.; 11432631|Galanis E, Goldberg R, Reid J, Atherton P, Sloan J, Pitot H, Rubin J, Adjei AA, Burch P, Saf
gren SL, Witzig TE, Ames MM, Erlichman C: Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd). Ann Oncol. 2001 May;12(5):701-7.

>  <iupac>
1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

>  <kegg_compound_id>
C00526

>  <metlin_id>
5086

>  <omim_id>
Not Available

>  <pubchem_compound_id>
13712

>  <secondary_id>
Not Available

>  <smiles_isomeric>
OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O

>  <Index>
2(1H)-pyrimidinone, 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-4-hydroxy-

>  <SMILES>
OC1=NC(=O)N(C=C1)[C@H]2C[C@H](O)[C@@H](CO)O2

>  <InChI>
InChI=1/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1

$$$$

  ACD/Labs07231008142D

 16 17  0  0  1  0  0  0  0  0  1 V2000
    4.4117   -2.6168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6398   -2.1728    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2781   -1.8327    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9677   -3.8733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9232   -0.8880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6412   -3.0608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2389   -2.6168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6452   -3.8733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1797   -0.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9124    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9071   -2.6452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9730   -2.2389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8894   -4.9786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1527   -1.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -3.1175    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4470   -0.9164    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  1  0  0  0  0
  5 10  2  0  0  0  0
  6 11  2  0  0  0  0
  7 12  1  1  0  0  0
  7  8  1  0  0  0  0
  8 13  1  6  0  0  0
  9 14  2  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  1  0  0  0  0
M  END
>  <HMDB_ID>
HMDB00014

>  <HMDB_Name>
Deoxycytidine

>  <cas_number>
951-77-9

>  <chebi_id>
Not Available

>  <description>
One of the principal nucleosides of DNA composed of cytosine and deoxyribose. A nucleoside consists of only a pentose sugar linked to a purine or pyrimidine base, without a phosphate group. When N1 is
 linked to the C1 of deoxyribose, deoxynucleosides and nucleotides are formed from cytosine and deoxyribose; deoxycytidine monophosphate (dCMP), deoxycytidine diphosphate (dCDP), deoxycytidine triphos
phate (dCTP). CTP is the source of the cytidine in RNA (ribonucleic acid) and deoxycytidine triphosphate (dCTP) is the source of the deoxycytidine in DNA (deoxyribonucleic acid).

>  <general_references>
15203276|van den Bosch J, Lubbert M, Verhoef G, Wijermans PW: The effects of 5-aza-2'-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndr
omes. Leuk Res. 2004 Aug;28(8):785-90.15116424|Lee SH, Jung BH, Kim SY, Chung BC: A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrome
try with direct urine injection. Rapid Commun Mass Spectrom. 2004;18(9):973-7.|Maley, F. et al., J. Biol. Chem., 1958, 233, 1538-1543, (5-diphosphate); |Charubala, R. et al., Synthesis, 1984, 965-968,
 (5'-(4,4'-dimethoxytrityl) 4N-benzoyl); |Schaller, H. et al., J.A.C.S., 1963, 85, 3821-3827, (5'-(4,4'-dimethoxytrityl) 4N-benzoyl); |Benz, E. et al., J.O.C., 1965, 30, 3067-3071, (4N-benzoyl, 5'-tos
yl, 3',4N-dibenzoyl, 4N,5'-dibenzoyl, 5'-tosyl 4N-benzoyl, 5'-trityl 3',4N-dibenzoyl); |Hruska, F.E. et al., Can. J. Chem., 1974, 52, 497-508, (pmr); 6714272|Wepierre J, Marty JP, Chanal JL, Sincholle
 D: Percutaneous absorption of 5-iodo-2' deoxycytidine in the hairless rat and in man. Eur J Drug Metab Pharmacokinet. 1984 Jan-Mar;9(1):79-83.; |Jones, A.J. et al., Proc. Natl. Acad. Sci. U.S.A., 197
0, 65, 27-30, CA, 72, 96682j, (cmr); |Miles, H.T., J.A.C.S., 1963, 85, 1007-1008, (ir, pmr); |Young, D.W. et al., Acta Cryst. B, 1975, 31, 961-965, (cryst struct); 12171902|Coral S, Sigalotti L, Altom
onte M, Engelsberg A, Colizzi F, Cattarossi I, Maraskovsky E, Jager E, Seliger B, Maio M: 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: 
immunotherapeutic implications. Clin Cancer Res. 2002 Aug;8(8):2690-5.|Michelson, A.M. et al., J.C.S., 1954, 34-40, (phosphates, 3',4N-di-Ac, 5'-trityl, 5'-trityl 3',4N-di-Ac); |Lewis, R.J., Sax's Dan
gerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, DAQ850; |Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 396A, 396C, (nmr); |Stawinski, J. et al., Chem. Comm.,
 1976, 243-244, (3',4N,5'-tribenzoyl); |Ulbricht, T.L.V. et al., J.C.S., 1965, 6134-6135, (3N-Me); |Wang, Z. et al., J.O.C., 2000, 65, 5969-5985, (synth, ir, pmr, cmr); |Saneyoshi, M. et al., Nucleic 
Acids Res., 1981, 9, 3129-3138, (5'-triphosphate, synth, uv, biochem); |Fox, J.J. et al., Adv. Carbohydr. Chem., 1959, 14, 283-380, (rev, derivs); |Saladino, R. et al., Tetrahedron, 1996, 52, 6759-678
0, (4N-Me, 4N-Et, 4N-(4-methylphenyl), synth, pmr, cmr); |Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 832B, 838D, 839C, (ir); 3243806|Olivares J, Verdys M: Isocratic high-performance liquid c
hromatographic method for studying the metabolism of blood plasma pyrimidine nucleosides and bases: concentration and radioactivity measurements. J Chromatogr. 1988 Dec 29;434(1):111-21.|Yang, J.T. et
 al., CA, 1966, 65, 12454, (ord)

>  <iupac>
4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-pyrimidin-2-one

>  <kegg_compound_id>
C00881

>  <metlin_id>
3367

>  <omim_id>
Not Available

>  <pubchem_compound_id>
13711

>  <secondary_id>
Not Available

>  <smiles_isomeric>
NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1

>  <Index>
cytidine, 2'-deoxy-

>  <SMILES>
NC1=NC(=O)N(C=C1)[C@H]2C[C@H](O)[C@@H](CO)O2

>  <InChI>
InChI=1/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1

$$$$
